Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by MAP4K4 is a member of the serine/threonine protein kinase family. Additionally we are shipping MAP4K4 Proteins (4) and MAP4K4 Kits (1) and many more products for this protein.
Showing 10 out of 154 products:
Human Monoclonal MAP4K4 Primary Antibody for WB - ABIN2869325
Becker, Huynh-Do, Holland, Pawson, Daniel, Skolnik: Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation. in Molecular and cellular biology 2000
Show all 3 references for ABIN2869325
Human Polyclonal MAP4K4 Primary Antibody for EIA - ABIN358366
Wright, Wang, Manning, LaMere, Le, Zhu, Khatry, Flanagan, Buckley, Whyte, Howlett, Bischoff, Lipson, Jallal: The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion. in Molecular and cellular biology 2003
Show all 3 references for ABIN358366
Human Monoclonal MAP4K4 Primary Antibody for ELISA, WB - ABIN969274
Poinat, De Arcangelis, Sookhareea, Zhu, Hedgecock, Labouesse, Georges-Labouesse: A conserved interaction between beta1 integrin/PAT-3 and Nck-interacting kinase/MIG-15 that mediates commissural axon navigation in C. elegans. in Current biology : CB 2002
Show all 3 references for ABIN969274
Human Polyclonal MAP4K4 Primary Antibody for EIA - ABIN358379
Yao, Zhou, Wang, Brown, Diener, Gan, Tan: A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway. in The Journal of biological chemistry 1999
Show all 3 references for ABIN358379
Human Monoclonal MAP4K4 Primary Antibody for IHC (p), ELISA - ABIN564078
Ma, Baumgartner: Filopodia and membrane blebs drive efficient matrix invasion of macrophages transformed by the intracellular parasite Theileria annulata. in PLoS ONE 2013
Show all 2 references for ABIN564078
Human Polyclonal MAP4K4 Primary Antibody for EIA, WB - ABIN360426
Austin, Rune, Bouzakri, Zierath, Krook: siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle. in Diabetes 2008
Show all 2 references for ABIN360426
Human Polyclonal MAP4K4 Primary Antibody for ICC, IF - ABIN439089
Xu, Takanashi, Oikawa, Nishi, Isaka, Yoshimoto, Ohyashiki, Kuroda: Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen. in Cancer science 2012
Chicken Polyclonal MAP4K4 Primary Antibody for IHC, WB - ABIN2783612
Bouzakri, Zierath: MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. in The Journal of biological chemistry 2007
miR (show MLXIP Antibodies)-194 regulated the progression of hepatocellular carcinoma through directly inhibiting the expression of MAP4K4
The results of the present study suggested that inhibition of MAP4K4 may be a therapeutic strategy for gastric cancer.
loss of MAP4K4 function suppressed pathological angiogenesis in disease models, identifying MAP4K4 as a potential therapeutic target
that MAP4K4, a known mediator of inflammation, is involved in KS aetiology by regulating KSHV lytic reactivation
results reveal a key target of SOX2 (show SOX2 Antibodies) expression and highlight the unexpected context-dependent role for MAP4K4, a pluripotent activator of several mitogen-activated protein kinase (show MAPK1 Antibodies) pathways, in regulating tumor cell survival.
TRAF1.NIK is a central complex linking canonical and non-canonical pathways by disrupting the TRAF2-cIAP2 ubiquitin ligase complex
Common polymorphisms in MAP4K4 are associated with insulin (show INS Antibodies) resistance and beta-cell dysfunction, possibly via this gene's role in inflammatory signaling.
Elevated MAP4K4 expression is closely associated with lung adenocarcinoma progression with independent prognostic value in predicting overall survival for patients with lung adenocarcinoma.
MAP4K4 overexpression is an independent predictor of poor prognosis of Hepatocellular Carcinoma patients, and inhibition of its expression might be of therapeutic significance
Data show that down-regulation of hepatocyte progenitor kinase-like kinase (HGK) can obviously inhibit the migration and invasion of HepG2 cells in vitro, and suggest that HGK may be a new therapeutic target for treatment of hepatocellular carcinoma.
These results reveal that MAP4K4 is a key signalling node that promotes immune cell recruitment in atherosclerosis.
Mice with Map4k4 deleted in Myf5 (show MYF5 Antibodies)-positive tissues, including all skeletal muscles tested, were protected from obesity-induced glucose intolerance and insulin (show INS Antibodies) resistance.
HGK/MAP4K4 deficiency has a role in inducing TRAF2 (show TRAF2 Antibodies) stabilization and Th17 differentiation leading to insulin (show INS Antibodies) resistance
microtubules can deliver MAP4K4 toward focal adhesions through ending binding 2
MAP4K4 is essential for CD4 (show CD4 Antibodies)+ T cell proliferation and activation in vitro through suppressing PKC-theta (show PRKCQ Antibodies) activation.
Map4k4 inhibits adipose lipogenesis by suppression of Srebp-1 (show SREBF1 Antibodies) in an AMPK (show PRKAA1 Antibodies)- and mTOR (show FRAP1 Antibodies)-dependent but JNK (show MAPK8 Antibodies)-independent mechanism.
Expression of a Map4k4 kinase-inactive mutant enhances myotube formation, suggesting that the kinase activity of Map4k4 is essential for its inhibition of muscle differentiation.
MicroRNA-30d induces insulin (show INS Antibodies) transcription factor MafA (show MAFA Antibodies) and insulin (show INS Antibodies) production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic beta-cells.
These findings suggest that scorpion venom induces insulin (show INS Antibodies) resistance by mechanisms involving TNF-alpha (show TNF Antibodies)-dependent Map4k4 kinase activation in the adipose tissue.
These data together with previous reports on extramedullary hemopoiesis in RelB (show RELB Antibodies)-deficient mice suggest that NIK-RelB (show RELB Antibodies) signaling may be involved in the suppression of extramedullary hemopoiesis in adult mice.
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified.
HPK/GCK-like kinase HGK
, MAPK/ERK kinase kinase kinase 4
, MEK kinase kinase 4
, Ste20 group protein kinase HGK
, hepatocyte progenitor kinase-like/germinal center kinase-like kinase
, nck-interacting kinase
, MEKKK 4
, NCK interacting kinase
, mitogen activated protein kinase kinase kinase kinase 4